Abstract
Abstract
Editing of ANGPTL3 was associated with few adverse events and resulted in reductions from baseline in ANGPTL3 levels. (Funded by CRISPR Therapeutics; Australia New Zealand Clinical Trials Registry number, ACTRN12623000809639.).
Direct answer
What can I do from this paper page?
Use this page to scan "Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Lipid metabolism and disorders research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Laffin2025Phase,
title = {Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3},
author = {Luke J Laffin and Stephen J. Nicholls and Russell Scott and Peter Clifton and John E. Baker and Ashish Sarraju and Shweta Singh and Qiuqing Wang and Kathy Wolski and Huansheng Xu and Jen Nielsen and Jason M. Duran and Steven E. Nissen},
journal = {New England Journal of Medicine},
year = {2025},
doi = {10.1056/nejmoa2511778},
url = {https://doi.org/10.1056/nejmoa2511778}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Lipid metabolism and disorders research papers?
Follow Lipid metabolism and disorders research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app